Skip to main content
. 2015 Oct 13;59(11):6913–6921. doi: 10.1128/AAC.01079-15

FIG 2.

FIG 2

Peak UrNGAL levels stratified by AKI status according to the KDIGObin criterion. Data are presented as the mean and standard error of the mean. The number of cases per group was as follows: n = 17 in the group with AKI and n = 7 in the group without AKI; for the subgroup receiving AmB deoxycholate, n = 10 patients with AKI and n = 2 patients without AKI; for the subgroup receiving liposomal AmB, n = 7 patients with AKI and n = 5 patients without AKI. The P value for trend was 0.15, and the order of the groups for the trend test was patients with AKI receiving AmB deoxycholate → patients with AKI receiving liposomal AmB → patients without AKI receiving AmB deoxycholate → patients without AKI receiving liposomal AmB.